Abstract
Rashes are among the most common manifestations of systemic lupus erythematosus (SLE), affecting up to 85% of individuals with SLE. Cutaneous lupus without systemic features is even more common than SLE. In many patients, cutaneous involvement can be widespread and debilitating, requiring systemic treatment. Here, two challenging cases of cutaneous lupus are described.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol. 2007;33(1–2):85–106.
Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol. 2004;22(2):129–38.
Patricio P, Ferreira C, Gomes MM, Filipe P. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci. 2009;1173:203–10.
Horne NS, Narayan AR, Young RM, Frieri M. Toxic epidermal necrolysis in systemic lupus erythematosus. Autoimmun Rev. 2006;5(2):160–4.
Paradela S, Martinez-Gomez W, Fernandez-Jorge B, Castineiras I, Yebra-Pimentel T, Llinares P, et al. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus. Lupus. 2007;16(9):741–5.
Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus. 2004;13(12):941–50.
Faye O, Roujeau JC. Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date. Drugs. 2005;65(15):2085–90.
Baltaci M, Fritsch P. Histologic features of cutaneous lupus erythematosus. Autoimmun Rev. 2009;8(6):467–73.
Kuhn A, Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus. 2008;17(5):389–93.
Kuhn A, Krammer PH, Kolb-Bachofen V. Pathophysiology of cutaneous lupus erythematosus–novel aspects. Rheumatology (Oxford). 2006;45 Suppl 3:iii14–6.
Srivastava M, Rencic A, Diglio G, Santana H, Bonitz P, Watson R, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139(1):45–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Criscione-Schreiber, L.G. (2010). Cutaneous Lupus. In: Mahmoudi, M. (eds) Challenging Cases in Allergic and Immunologic Diseases of the Skin. Springer, New York, NY. https://doi.org/10.1007/978-1-60761-296-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-296-4_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-60761-295-7
Online ISBN: 978-1-60761-296-4
eBook Packages: MedicineMedicine (R0)